We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
-3.36%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$515M
AUM Growth
-$30.1M
Cap. Flow
-$7.12M
Cap. Flow %
-1.38%
Top 10 Hldgs %
16.03%
Holding
304
New
12
Increased
100
Reduced
100
Closed
22

Top Buys

Rank Stock Value
1
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$1.65M
2
ETN icon
Eaton
ETN
+$645K
3
OII icon
Oceaneering
OII
+$550K
4
CTSH icon
Cognizant
CTSH
+$485K
5
BPL
Buckeye Partners, L.P.
BPL
+$414K

Top Sells

Rank Stock Value
1
TCOM icon
Trip.com Group
TCOM
+$1.19M
2
AME icon
Ametek
AME
+$1.17M
3
AMX icon
America Movil
AMX
+$674K
4
JPM icon
JPMorgan Chase
JPM
+$542K
5
C icon
Citigroup
C
+$501K

Sector Composition

Rank Sector Weight
1 Technology 21.45%
2 Industrials 17.09%
3 Financials 8.7%
4 Healthcare 8.6%
5 Energy 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DUK icon
126
Duke Energy
DUK
$102B
$1.06M 0.21%
14,207
– –
CBST
127
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$1.03M 0.2%
15,554
-994
-6% -$65.3K
BP icon
128
BP
BP
$113B
$1.02M 0.2%
28,510
-677
-2% -$26.8K
CEMI
129
DELISTED
Chembio diagnostics, Inc.
CEMI
$1.01M 0.2%
272,287
-36,632
-12% -$128K
BNY
130
Bank of New York Mellon
BNY
$108B
$1.01M 0.2%
26,020
– –
PRU icon
131
Prudential Financial
PRU
$41.7B
$992K 0.19%
11,278
– –
CMT icon
132
Core Molding Technologies
CMT
$210M
$956K 0.19%
66,780
-8,767
-12% -$119K
STX icon
133
Seagate
STX
$193B
$897K 0.17%
15,660
– –
ZIXI
134
DELISTED
Zix Corporation
ZIXI
$844K 0.16%
246,761
-25,318
-9% -$90.5K
ESRX
135
DELISTED
Express Scripts Holding Company
ESRX
$840K 0.16%
11,897
– –
MG icon
136
Mistras Group
MG
$492M
$836K 0.16%
40,976
-5,663
-12% -$124K
F icon
137
Ford
F
$57.3B
$821K 0.16%
55,494
+1,146
+2% +$19.6K
SPG icon
138
Simon Property Group
SPG
$74.5B
$814K 0.16%
4,950
– –
CF icon
139
CF Industries
CF
$19.2B
$794K 0.15%
14,210
-405
-3% -$20.6K
MMM icon
140
3M
MMM
$89B
$782K 0.15%
6,600
– –
ULTA icon
141
Ulta Beauty
ULTA
$20.4B
$765K 0.15%
6,475
+386
+6% +$38.4K
RRC icon
142
Range Resources
RRC
$9.11B
$758K 0.15%
11,175
+175
+2% +$13.4K
TEVA icon
143
Teva Pharmaceuticals
TEVA
$35.9B
$753K 0.15%
14,000
– –
CNI icon
144
Canadian National Railway
CNI
$78.3B
$748K 0.15%
10,540
+931
+10% +$64.5K
UNH icon
145
UnitedHealth
UNH
$382B
$748K 0.15%
8,670
+299
+4% +$25.3K
ECOL
146
DELISTED
US Ecology, Inc.
ECOL
$744K 0.14%
15,903
-3,637
-19% -$167K
DD icon
147
DuPont de Nemours
DD
$18.6B
$740K 0.14%
5,576
– –
DO
148
DELISTED
Diamond Offshore Drilling
DO
$726K 0.14%
21,197
+869
+4% +$38.4K
BA icon
149
Boeing
BA
$165B
$724K 0.14%
5,681
-122
-2% -$15.4K
COST icon
150
Costco
COST
$415B
$721K 0.14%
5,757
+312
+6% +$37.7K
4 5
6
7 8

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Stanley-Laman Group's Q3 2014 Portfolio in Review

As of Q3 2014, Stanley-Laman Group held 304 positions worth $515M, down 5.5% from $545M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Stanley-Laman Group's Q3 2014 filing shows 12 new, 100 increased, 100 reduced and 22 closed positions. Its largest new stake was Eagle Pharmaceuticals, Inc.: 132,790 shares worth $1.68M. The largest sale was Trip.com Group, an estimated $1.19M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Industrials and Financials.

  • Stanley-Laman Group's largest Q3 2014 buy was Eagle Pharmaceuticals, Inc.: 132,790 shares worth $1.68M.
  • Stanley-Laman Group added most to Eaton in Q3 2014, an estimated $645K increase.
  • Stanley-Laman Group's biggest Q3 2014 reduction was Trip.com Group, cutting an estimated $1.19M.
  • Stanley-Laman Group fully exited Ametek in Q3 2014, selling an estimated $1.17M.
  • Stanley-Laman Group's ten largest holdings make up 16% of its $515M portfolio in Q3 2014.
  • Stanley-Laman Group opened 12 new positions and closed 22 in Q3 2014.
  • Stanley-Laman Group's portfolio value fell 5.5% quarter-over-quarter to $515M.

Based on Stanley-Laman Group's 13F filing for Q3 2014, filed 14 Nov 2014.